The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. - Université de Lille Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Autoimmunity Reviews Année : 2023

The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.

Résumé

Objectives The study aim was to evaluate the predictive role of the echocardiography-derived tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio for pulmonary hypertension (PH) diagnosis and mortality in the European Scleroderma Trials and Research (EUSTAR) cohort. Methods Eligible patients were systemic sclerosis (SSc) patients registered in the EUSTAR database with at least one visit recording TAPSE and sPAP data. Individual centres were required to provide TAPSE and sPAP data at 12 ± 3 months before right heart catheterization (RHC). Logistic regression analysis was applied to analyse the predictive ability of TAPSE/sPAP ratio for PH diagnosis. Cox regression analysis was performed to evaluate TAPSE/sPAP ratio as a predictive factor for all-cause mortality. Results 2555 SSc patients met the inclusion criteria for this study with 355 SSc patients having available RHC data at baseline. PH was confirmed by RHC in 195 SSc patients (54.9%). TAPSE/sPAP ratio < 0.55 mm/mmHg [OR 0.251 (95% CI 0.084–0.753), p < 0.05] and FVC/DLCO [OR 2.568 (95% CI 1.227–5.375), p < 0.05] were significantly associated with PH diagnosis. In logistic regression analysis with echocardiographic parameters at 12 ± 3 months before RHC, TAPSE/sPAP ratio < 0.55 mm/mmHg [OR 0.265 (95% CI 0.102–0.685), p < 0.01] and FVC/DLCO [OR 2.529 (95% CI 1.358–4.711), p < 0.01] were associated with PH diagnosis. In multivariate Cox regression analysis, TAPSE/sPAP ratio ≤ 0.32 mm/mmHg [HR 0.310 (0.164–0.585), p < 0.001] was the most significant predictive factor for death. Conclusions TAPSE/sPAP ratio < 0.55 mm/mmHg is a predictive risk factor for PH. TAPSE/sPAP ratio ≤ 0.32 mm/mmHg is a predictive risk marker for all-cause mortality.
Fichier principal
Vignette du fichier
1-s2.0-S1568997223000241-main.pdf (742.61 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04488026 , version 1 (04-03-2024)

Licence

Paternité

Identifiants

Citer

Amalia Colalillo, Anna-Maria Hoffmann-Vold, Chiara Pellicano, Antonella Romaniello, Armando Gabrielli, et al.. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort.. Autoimmunity Reviews, 2023, Autoimmunity Reviews, 22, pp.103290. ⟨10.1016/j.autrev.2023.103290⟩. ⟨hal-04488026⟩

Collections

RIIP UNIV-LILLE
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More